PDB Short entry for 2CXF HEADER PROTEIN BINDING 29-JUN-05 2CXF TITLE RUN DOMAIN OF RAP2 INTERACTING PROTEIN X, CRYSTALLIZED IN TITLE 2 C2 SPACE GROUP COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAP2 INTERACTING PROTEIN X; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RUN DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PX040220-04; SOURCE 7 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS HELIX BUNDLE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT KEYWDS 2 ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN KEYWDS 3 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, PROTEIN KEYWDS 4 BINDING EXPDTA X-RAY DIFFRACTION AUTHOR M.KUKIMOTO-NIINO,K.MURAYAMA,M.SHIROUZU,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 24-FEB-09 2CXF 1 VERSN REVDAT 3 24-OCT-06 2CXF 1 JRNL REVDAT 2 29-AUG-06 2CXF 1 HEADER REMARK SOURCE TITLE REVDAT 1 29-DEC-05 2CXF 0 JRNL AUTH M.KUKIMOTO-NIINO,T.TAKAGI,R.AKASAKA,K.MURAYAMA, JRNL AUTH 2 T.UCHIKUBO-KAMO,T.TERADA,M.INOUE,S.WATANABE, JRNL AUTH 3 A.TANAKA,Y.HAYASHIZAKI,T.KIGAWA,M.SHIROUZU, JRNL AUTH 4 S.YOKOYAMA JRNL TITL CRYSTAL STRUCTURE OF THE RUN DOMAIN OF THE JRNL TITL 2 RAP2-INTERACTING PROTEIN X JRNL REF J.BIOL.CHEM. V. 281 31843 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16928684 JRNL DOI 10.1074/JBC.M604960200 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 3.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1292738.580 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.5 REMARK 3 NUMBER OF REFLECTIONS : 3294 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 324 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.016 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 22.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 141 REMARK 3 BIN R VALUE (WORKING SET) : 0.3310 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 15 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.093 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1301 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 99.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.09000 REMARK 3 B22 (A**2) : -43.45000 REMARK 3 B33 (A**2) : 51.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 43.38000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM SIGMAA (A) : 0.38 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.49 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.003 REMARK 3 BOND ANGLES (DEGREES) : 0.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 17.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.49 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.27 REMARK 3 BSOL : 23.51 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CXF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-JUL-05. REMARK 100 THE RCSB ID CODE IS RCSB024734. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97899, 0.97935, 0.96400 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 3507 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 200 DATA REDUNDANCY : 3.407 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0717 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.13000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.351 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20000, BICINE, DIOXANE, PH 9.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 43.30950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.79600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 43.30950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.79600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 76 REMARK 465 SER A 77 REMARK 465 SER A 78 REMARK 465 GLY A 79 REMARK 465 SER A 80 REMARK 465 SER A 81 REMARK 465 GLY A 82 REMARK 465 GLN A 250 REMARK 465 VAL A 251 REMARK 465 GLY A 252 REMARK 465 VAL A 253 REMARK 465 ILE A 254 REMARK 465 ASP A 255 REMARK 465 PHE A 256 REMARK 465 SER A 257 REMARK 465 MSE A 258 REMARK 465 TYR A 259 REMARK 465 LEU A 260 REMARK 465 LYS A 261 REMARK 465 ASP A 262 REMARK 465 GLY A 263 REMARK 465 ASN A 264 REMARK 465 SER A 265 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 135 -146.83 -121.67 REMARK 500 SER A 146 -122.95 57.16 REMARK 500 LYS A 156 35.74 -78.85 REMARK 500 LEU A 157 -29.52 -153.83 REMARK 500 ALA A 162 -6.75 -59.22 REMARK 500 ASP A 170 27.94 -73.60 REMARK 500 LYS A 175 -79.21 -84.31 REMARK 500 THR A 176 131.41 -39.33 REMARK 500 LYS A 205 1.51 -67.53 REMARK 500 GLU A 213 -164.80 -66.46 REMARK 500 ASN A 239 95.65 -175.95 REMARK 500 ASP A 246 7.00 -156.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CXL RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN I422 SPACE GROUP REMARK 900 RELATED ID: 2DWG RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN P2(1)P2(1)P2(1) SPACE GROUP REMARK 900 RELATED ID: 2DWK RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN P6(4)22 SPACE GROUP REMARK 900 RELATED ID: MMK001003772.2 RELATED DB: TARGETDB DBREF 2CXF A 83 265 UNP Q9D394 Q9D394_MOUSE 65 247 SEQADV 2CXF GLY A 76 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF SER A 77 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF SER A 78 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF GLY A 79 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF SER A 80 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF SER A 81 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF GLY A 82 UNP Q9D394 CLONING ARTIFACT SEQADV 2CXF MSE A 83 UNP Q9D394 MET 65 MODIFIED RESIDUE SEQADV 2CXF MSE A 88 UNP Q9D394 MET 70 MODIFIED RESIDUE SEQADV 2CXF MSE A 91 UNP Q9D394 MET 73 MODIFIED RESIDUE SEQADV 2CXF MSE A 93 UNP Q9D394 MET 75 MODIFIED RESIDUE SEQADV 2CXF MSE A 126 UNP Q9D394 MET 108 MODIFIED RESIDUE SEQADV 2CXF MSE A 190 UNP Q9D394 MET 172 MODIFIED RESIDUE SEQADV 2CXF MSE A 198 UNP Q9D394 MET 180 MODIFIED RESIDUE SEQADV 2CXF MSE A 218 UNP Q9D394 MET 200 MODIFIED RESIDUE SEQADV 2CXF MSE A 219 UNP Q9D394 MET 201 MODIFIED RESIDUE SEQADV 2CXF MSE A 242 UNP Q9D394 MET 224 MODIFIED RESIDUE SEQADV 2CXF MSE A 258 UNP Q9D394 MET 240 MODIFIED RESIDUE SEQRES 1 A 190 GLY SER SER GLY SER SER GLY MSE ALA ASN GLU ARG MSE SEQRES 2 A 190 ASN LEU MSE ASN MSE ALA LYS LEU SER ILE LYS GLY LEU SEQRES 3 A 190 ILE GLU SER ALA LEU ASN LEU GLY ARG THR LEU ASP SER SEQRES 4 A 190 ASP TYR ALA PRO LEU GLN GLN PHE PHE VAL VAL MSE GLU SEQRES 5 A 190 HIS CYS LEU LYS HIS GLY LEU LYS ALA LYS LYS THR PHE SEQRES 6 A 190 LEU GLY GLN ASN LYS SER PHE TRP GLY PRO LEU GLU LEU SEQRES 7 A 190 VAL GLU LYS LEU VAL PRO GLU ALA ALA GLU ILE THR ALA SEQRES 8 A 190 SER VAL LYS ASP LEU PRO GLY LEU LYS THR PRO VAL GLY SEQRES 9 A 190 ARG GLY ARG ALA TRP LEU ARG LEU ALA LEU MSE GLN LYS SEQRES 10 A 190 LYS LEU SER GLU TYR MSE LYS ALA LEU ILE ASN LYS LYS SEQRES 11 A 190 GLU LEU LEU SER GLU PHE TYR GLU VAL ASN ALA LEU MSE SEQRES 12 A 190 MSE GLU GLU GLU GLY ALA ILE ILE ALA GLY LEU LEU VAL SEQRES 13 A 190 GLY LEU ASN VAL ILE ASP ALA ASN PHE CYS MSE LYS GLY SEQRES 14 A 190 GLU ASP LEU ASP SER GLN VAL GLY VAL ILE ASP PHE SER SEQRES 15 A 190 MSE TYR LEU LYS ASP GLY ASN SER MODRES 2CXF MSE A 83 MET SELENOMETHIONINE MODRES 2CXF MSE A 88 MET SELENOMETHIONINE MODRES 2CXF MSE A 91 MET SELENOMETHIONINE MODRES 2CXF MSE A 93 MET SELENOMETHIONINE MODRES 2CXF MSE A 126 MET SELENOMETHIONINE MODRES 2CXF MSE A 190 MET SELENOMETHIONINE MODRES 2CXF MSE A 198 MET SELENOMETHIONINE MODRES 2CXF MSE A 218 MET SELENOMETHIONINE MODRES 2CXF MSE A 219 MET SELENOMETHIONINE MODRES 2CXF MSE A 242 MET SELENOMETHIONINE HET MSE A 83 8 HET MSE A 88 8 HET MSE A 91 8 HET MSE A 93 8 HET MSE A 126 8 HET MSE A 190 8 HET MSE A 198 8 HET MSE A 218 8 HET MSE A 219 8 HET MSE A 242 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 10(C5 H11 N O2 SE) HELIX 1 1 MSE A 83 GLY A 109 1 27 HELIX 2 2 TYR A 116 LYS A 131 1 16 HELIX 3 3 PHE A 147 LEU A 153 1 7 HELIX 4 4 VAL A 154 LEU A 157 5 4 HELIX 5 5 VAL A 158 PRO A 159 5 2 HELIX 6 6 GLU A 160 VAL A 168 1 9 HELIX 7 7 THR A 176 GLN A 191 1 16 HELIX 8 8 LYS A 193 ASN A 203 1 11 HELIX 9 9 LEU A 207 TYR A 212 1 6 HELIX 10 10 GLU A 220 LEU A 230 1 11 HELIX 11 11 VAL A 231 ASN A 234 5 4 LINK C MSE A 83 N ALA A 84 1555 1555 1.33 LINK C ARG A 87 N MSE A 88 1555 1555 1.33 LINK C MSE A 88 N ASN A 89 1555 1555 1.33 LINK C LEU A 90 N MSE A 91 1555 1555 1.33 LINK C MSE A 91 N ASN A 92 1555 1555 1.33 LINK C ASN A 92 N MSE A 93 1555 1555 1.33 LINK C MSE A 93 N ALA A 94 1555 1555 1.33 LINK C VAL A 125 N MSE A 126 1555 1555 1.33 LINK C MSE A 126 N GLU A 127 1555 1555 1.33 LINK C LEU A 189 N MSE A 190 1555 1555 1.33 LINK C MSE A 190 N GLN A 191 1555 1555 1.33 LINK C TYR A 197 N MSE A 198 1555 1555 1.33 LINK C MSE A 198 N LYS A 199 1555 1555 1.33 LINK C LEU A 217 N MSE A 218 1555 1555 1.33 LINK C MSE A 218 N MSE A 219 1555 1555 1.33 LINK C MSE A 219 N GLU A 220 1555 1555 1.33 LINK C CYS A 241 N MSE A 242 1555 1555 1.33 LINK C MSE A 242 N LYS A 243 1555 1555 1.33 CRYST1 86.619 41.592 62.132 90.00 105.95 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011545 0.000000 0.003300 0.00000 SCALE2 0.000000 0.024043 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016739 0.00000 HETATM 1 N MSE A 83 18.876 -2.893 33.247 1.00166.21 N HETATM 2 CA MSE A 83 18.857 -3.130 31.775 1.00168.10 C HETATM 3 C MSE A 83 18.923 -1.807 31.020 1.00168.81 C HETATM 4 O MSE A 83 19.759 -1.625 30.135 1.00168.62 O HETATM 5 CB MSE A 83 17.583 -3.882 31.380 1.00168.38 C HETATM 6 CG MSE A 83 17.496 -4.237 29.901 1.00170.31 C HETATM 7 SE MSE A 83 18.819 -5.534 29.342 1.00172.53 SE HETATM 8 CE MSE A 83 20.251 -4.330 28.875 1.00162.73 C